Welcome to LookChem.com Sign In|Join Free
  • or
Mevalonate, a key intermediate in the synthesis of isoprenoids, is a crucial component in the mevalonate pathway, which is essential for the biosynthesis of important cellular components such as dolichol, ubiquinone, and heme A, as well as for the production of isoprenoid-derived metabolites. It is synthesized from acetyl-CoA through a series of enzymatic reactions and serves as a precursor for the synthesis of squalene, a key intermediate in the biosynthesis of cholesterol and steroid hormones. Due to its pivotal role in cellular metabolism, mevalonate and its derivatives have been identified as potential targets for the development of novel drugs for various diseases, including cancer, cardiovascular disorders, and metabolic syndromes.

1192-42-3

Post Buying Request

1192-42-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1192-42-3 Usage

Uses

Used in Pharmaceutical Industry:
Mevalonate is used as a precursor for the synthesis of cholesterol, steroids, and various hormones, which are essential for maintaining normal physiological functions in the human body. Its role in the mevalonate pathway makes it a potential target for the development of novel drugs for various diseases.
Used in Drug Development for Cancer Treatment:
Mevalonate is used as a target for the development of novel drugs for cancer treatment, as its inhibition can disrupt the synthesis of cholesterol and steroid hormones, which are often overproduced in cancer cells, leading to their growth and proliferation.
Used in Drug Development for Cardiovascular Disorders:
Mevalonate is used as a target for the development of novel drugs for cardiovascular disorders, as its inhibition can help regulate cholesterol levels and reduce the risk of atherosclerosis and other related conditions.
Used in Drug Development for Metabolic Syndromes:
Mevalonate is used as a target for the development of novel drugs for metabolic syndromes, as its inhibition can help regulate lipid metabolism and improve insulin sensitivity, reducing the risk of developing type 2 diabetes and other metabolic disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 1192-42-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 2 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1192-42:
(6*1)+(5*1)+(4*9)+(3*2)+(2*4)+(1*2)=63
63 % 10 = 3
So 1192-42-3 is a valid CAS Registry Number.

1192-42-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-3,5-dihydroxy-3-methylpentanoate

1.2 Other means of identification

Product number -
Other names 3-Hydroxy-3-methyl-dihydro-furan-2-on

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1192-42-3 SDS

1192-42-3Relevant academic research and scientific papers

Enantioselective syntheses of substituted γ-butyrolactones

Eliel, Ernest L.,Bai, Xu,Ohwa, Masaki

, p. 63 - 70 (2007/10/03)

The previously described chiral 2-acyloxathianes 5 (Scheme I) are used in two different enantioselective syntheses of γ-butyrolactones. In one synthesis, Grignard addition, cleavage and reduction to carbinols RR'C(OH)CH2OH is followed by tosylation, malonate homologation, lactonization, and removal of the carbomethoxy group to give optically active γ-lactones. A modification of this synthesis (Scheme I) leads to optically active α-methylene-γ-lactones. In the second synthesis, reaction of a bromomagnesium enolate with ketones 5 leads to β-hydroxyesters, which, by appropriate sequences of reduction and cleavage (Scheme II) are converted to optically active α- or β-hydroxy-γ-lactones.

Asymmetric synthesis of α-alkyl-α-hydroxy-γ-butyrolactones

Pansare, Sunil V.,Jain, Rajendra P.,Ravi, R. Gnana

, p. 3103 - 3106 (2007/10/03)

A new enantioselective approach to α-alkyl-α-hydroxy-γ-butyrolactones employing (1R,2S)-ephedrine-derived chiral allyl morpholinones as starting materials is described.

Preparation of α-Hydroxy-γ-lactones and their Application in the Synthesis of α,β-Butenolides, α-Alkylidene-γ-lactones and Furans

Munoz, A. Heber,Tamariz, Joaquin,Jimenez, Rogelio,Mora, Gustavo Garcia de la

, p. 501 - 522 (2007/10/02)

A straightforward synthesis of α-hydroxy-γ-butyrolactones was carried out by condensation reaction of the lithium anion of ethoxyethyl-protected cyanohydrins with epoxides, followed by acidic treatment.Synthetic applications of these synthons in the preparation of interesting α,β-butenolides, α-alkylidene-γ-lactones and furans are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1192-42-3